Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hidetoshi Mima"'
Autor:
Katsuto Tamai, Seiji Yamamoto, Ryuji Tomoshige, Yasufumi Kaneda, Makoto Ito, Hidetoshi Mima, Yasuhiko Tabata
Publikováno v:
Molecular Cancer Therapeutics. 5:1021-1028
The hemagglutinating virus of Japan envelope (HVJ-E; Sendai virus) vector derived from inactivated HVJ particles can be used to deliver DNA, proteins, and drugs into cells both in vitro and in vivo. HVJ-E is capable of delivering bleomycin, an antica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712b0a3a84b1e727b3b258fa521d211b
https://doi.org/10.1158/1535-7163.mct-05-0352
https://doi.org/10.1158/1535-7163.mct-05-0352
Biocompatible polymer enhances thein vitro andin vivo transfection efficiency of HVJ envelope vector
Autor:
Seiji Yamamoto, Katsuto Tamai, Yasuhiko Tabata, Yasufumi Kaneda, Hidetoshi Mima, Ryuji Tomoshige, Susumu Ito, Toshihide Kanamori
Publikováno v:
The Journal of Gene Medicine. 7:888-897
Background Vector development is critical for the advancement of human gene therapy. However, the use of viral vectors raises many safety concerns and most non-viral methods are less efficient for gene transfer. One of the breakthroughs in vector tec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8bec043e217eef9d5baed357c040ef
https://doi.org/10.1002/jgm.735
https://doi.org/10.1002/jgm.735
Autor:
Seiji Yamamoto, Susumu Ito, Hidetoshi Mima, Yasuhiko Tabata, Katsuto Tamai, Ryuji Tomoshige, Yasufumi Kaneda
Publikováno v:
Molecular Therapy. 11:S85
Vector development is critical for the advancement of human gene therapy. However, the use of viral vectors raises many safety concerns and most non-viral methods are less efficient for gene transfer. One of the breakthroughs in vector technology is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81cc1ed6fc04fc4c1e3136bfa8b92ae5
https://doi.org/10.1016/j.ymthe.2005.06.219
https://doi.org/10.1016/j.ymthe.2005.06.219